Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1101 | 1018 | 1129 | 1235 | 1324 | 1838 |
Fund Return | 10.06% | 1.79% | 12.91% | 7.3% | 5.78% | 6.27% |
Place in category | 221 | 425 | 278 | 223 | 142 | 81 |
% in Category | 35 | 62 | 44 | 45 | 29 | 22 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HSBC American Index Fund Accumulati | 9.63B | 14.92 | 11.03 | 15.02 | ||
HSBC American Index Fund Income C | 708M | 14.91 | 11.02 | 15.01 | ||
HSBC American Index Fund Retail Acc | 234.05M | 7.05 | 14.75 | 15.32 | ||
HSBC American Index Fund Retail Inc | 1.48M | 7.05 | 15.24 | 15.46 | ||
HSFund Institutional Accumulation | 4.61B | 7.07 | 14.89 | 15.50 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 14.17B | 8.44 | 6.12 | 6.19 | ||
VG UK Institutional Plus GBP Income | 14.17B | -0.69 | 7.90 | - | ||
All Share Index Unit Trust Income | 14.17B | -0.70 | 7.89 | - | ||
VG UK Plus GBP Accumulation | 14.17B | -0.70 | 7.91 | - | ||
UK Equity Tracker Fund D Acc | 11.43B | 7.77 | 6.38 | 6.24 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 7.14 | 10,144.0 | +1.54% | |
Shell | GB00BP6MXD84 | 6.25 | 30.72 | +0.29% | |
HSBC | GB0005405286 | 5.10 | 700.80 | +0.99% | |
Unilever | GB00B10RZP78 | 4.93 | 54.32 | +0.22% | |
Relx | GB00B2B0DG97 | 2.70 | 3,607.00 | -0.74% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review